These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 6654758)
1. Structural studies on pyrrolomycins C, D and E. Koyama M; Ezaki N; Tsuruoka T; Inouye S J Antibiot (Tokyo); 1983 Nov; 36(11):1483-9. PubMed ID: 6654758 [TBL] [Abstract][Full Text] [Related]
2. Pyrrolomycins C, D and E, new members of pyrrolomycins. Ezaki N; Koyama M; Shomura T; Tsuruoka T; Inouye S J Antibiot (Tokyo); 1983 Oct; 36(10):1263-7. PubMed ID: 6685720 [TBL] [Abstract][Full Text] [Related]
3. Pyrrolomycins F1, F2a, F2b and F3, new metabolites produced by the addition of bromide to the fermentation. Ezaki N; Koyama M; Kodama Y; Shomura T; Tashiro K; Tsuruoka T; Inouye S; Sakai S J Antibiot (Tokyo); 1983 Nov; 36(11):1431-8. PubMed ID: 6686223 [TBL] [Abstract][Full Text] [Related]
9. Novel fluorinated pyrrolomycins as potent anti-staphylococcal biofilm agents: Design, synthesis, pharmacokinetics and antibacterial activities. Yang Z; Liu Y; Ahn J; Qiao Z; Endres JL; Gautam N; Huang Y; Li J; Zheng J; Alnouti Y; Bayles KW; Li R Eur J Med Chem; 2016 Nov; 124():129-137. PubMed ID: 27565555 [TBL] [Abstract][Full Text] [Related]
10. Pyrrolomycins as potential anti-staphylococcal biofilms agents. Schillaci D; Petruso S; Raimondi MV; Cusimano MG; Cascioferro S; Scalisi M; La Giglia MA; Vitale M Biofouling; 2010; 26(4):433-8. PubMed ID: 20234952 [TBL] [Abstract][Full Text] [Related]
11. Pyrrolomycin group antibiotics inhibit substance P-induced release of myeloperoxidase from human polymorphonuclear leukocytes. Masuda K; Suzuki K; Ishida-Okawara A; Mizuno S; Hotta K; Miyadoh S; Hara O; Koyama M J Antibiot (Tokyo); 1991 May; 44(5):533-40. PubMed ID: 1712007 [TBL] [Abstract][Full Text] [Related]
12. Structure and synthesis of pyrrolomycin A, a chlorinated nitro-pyrrole antibiotic. Koyama M; Kodama Y; Tsuruoka T; Ezaki N; Niwa T; Inouye S J Antibiot (Tokyo); 1981 Dec; 34(12):1569-76. PubMed ID: 7333969 [No Abstract] [Full Text] [Related]
13. 3,4,5,3',5'-Pentabromo-2-(2'-hydroxybenzoyl)pyrrole: a potential lead compound as anti-Gram-positive and anti-biofilm agent. Schillaci D; Petruso S; Sciortino V Int J Antimicrob Agents; 2005 Apr; 25(4):338-40. PubMed ID: 15784315 [TBL] [Abstract][Full Text] [Related]
14. APHE-3 and APHE-4, two new pyrazoloisoquinolinone antibiotics produced by Streptoverticillium griseocarneum NCIMB 40447. Cruz R; Arias MS; Arias ME; Soliveri J J Antibiot (Tokyo); 1996 Jul; 49(7):700-2. PubMed ID: 8784435 [No Abstract] [Full Text] [Related]
15. Pharmaceutical Potential of Synthetic and Natural Pyrrolomycins. Cascioferro S; Raimondi MV; Cusimano MG; Raffa D; Maggio B; Daidone G; Schillaci D Molecules; 2015 Dec; 20(12):21658-71. PubMed ID: 26690095 [TBL] [Abstract][Full Text] [Related]
16. Draft Genome Sequence of Streptomyces vitaminophilus ATCC 31673, a Producer of Pyrrolomycin Antibiotics, Some of Which Contain a Nitro Group. Mahan KM; Klingeman DM; Hettich RL; Parry RJ; Graham DE Genome Announc; 2016 Jan; 4(1):. PubMed ID: 26798098 [TBL] [Abstract][Full Text] [Related]
17. In vitro anti-Gram-positive and antistaphylococcal biofilm activity of newly halogenated pyrroles related to pyrrolomycins. Schillaci D; Petruso S; Cascioferro S; Raimondi MV; Haagensen JA; Molin S Int J Antimicrob Agents; 2008 Apr; 31(4):380-2. PubMed ID: 18082373 [No Abstract] [Full Text] [Related]